European markets set to inch higher on Pfizer vaccine approval and easing taper worries

European stocks are set for a slightly higher open on Tuesday as investors take heart from the U.S. FDA's full approval of the Pfizer/BioNTech vaccine.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.